Viewing Study NCT04788433



Ignite Creation Date: 2024-05-06 @ 3:52 PM
Last Modification Date: 2024-10-26 @ 1:59 PM
Study NCT ID: NCT04788433
Status: COMPLETED
Last Update Posted: 2023-04-04
First Post: 2021-03-07

Brief Title: Registry of Coronavirus Complications - CORRELATION WITH GLYCOMIC PROFILE in COVID-19 Patients
Sponsor: Papa Giovanni XXIII Hospital
Organization: Papa Giovanni XXIII Hospital

Study Overview

Official Title: ROCCO - Registry of Coronavirus Complications Prospective Observational Study on Coronavirus Complications and Correlation With Glycomic Profile in COVID-19 Patients
Status: COMPLETED
Status Verified Date: 2023-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: ROCCO
Brief Summary: COVID infection has resulted in multi-organ injury and may result in cardiovascular pulmonary neurological and muscular damage It is associated with significant asthenia and the long-term effects of the infection are still unclear particularly for the development of pain and delayed functional rehabilitation

Glycomics is the systematic study of the structure of glycans in a given cell type or organism Glycans are complex oligosaccharides attached to proteins and lipids that regulate a variety of organic processes including immunity Thus glycans may influence different moments of the response to the virus and involved in the clinical severity of the disease but may also change depending on the severity of symptoms and the organic response to SARS-CoV-2 infection

Glycomic data could provide important insights into interindividual differences at the molecular level that directly interact with SARS-CoV-2 and the development of mid- and long-term side effects The ability to identify early those susceptible to developing COVID-19 infection and at higher risk for COVID-19 with unfavorable outcomes long after infection would help guide therapeutic strategy and provide important guidance for rational health care organization which is of outmost importance

Long-term outcome data regarding post-COVID patient functional capacity and glycomics will be compared to assess whether there may be differences in protein glycosylation that may predict patient outcome
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None